Quidel Current Ratio 2006-2018 | QDEL

Quidel current ratio from 2006 to 2018. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
Quidel Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2018-12-31 $0.19B $0.16B 1.21
2018-09-30 $0.20B $0.16B 1.26
2018-06-30 $0.17B $0.15B 1.10
2018-03-31 $0.27B $0.20B 1.36
2017-12-31 $0.33B $0.13B 2.58
2017-09-30 $0.24B $0.04B 6.28
2017-06-30 $0.23B $0.03B 7.19
2017-03-31 $0.25B $0.03B 8.41
2016-12-31 $0.23B $0.03B 6.71
2016-09-30 $0.21B $0.03B 8.23
2016-06-30 $0.20B $0.02B 8.60
2016-03-31 $0.21B $0.03B 7.46
2015-12-31 $0.24B $0.03B 7.81
2015-09-30 $0.25B $0.04B 6.91
2015-06-30 $0.26B $0.03B 7.62
2015-03-31 $0.29B $0.04B 7.90
2014-12-31 $0.27B $0.04B 7.54
2014-09-30 $0.09B $0.03B 2.88
2014-06-30 $0.07B $0.02B 3.67
2014-03-31 $0.08B $0.02B 3.42
2013-12-31 $0.08B $0.02B 3.28
2013-09-30 $0.07B $0.02B 3.33
2013-06-30 $0.07B $0.02B 3.90
2013-03-31 $0.09B $0.02B 4.01
2012-12-31 $0.08B $0.02B 3.32
2012-09-30 $0.07B $0.02B 4.48
2012-06-30 $0.06B $0.01B 4.98
2012-03-31 $0.07B $0.02B 4.44
2011-12-31 $0.10B $0.03B 3.17
2011-09-30 $0.09B $0.03B 2.74
2011-06-30 $0.10B $0.02B 6.42
2011-03-31 $0.11B $0.02B 5.53
2010-12-31 $0.06B $0.02B 3.55
2010-09-30 $0.06B $0.02B 3.24
2010-06-30 $0.07B $0.02B 3.81
2010-03-31 $0.08B $0.02B 4.11
2009-12-31 $0.13B $0.03B 4.28
2009-09-30 $0.11B $0.02B 4.68
2009-06-30 $0.08B $0.01B 7.89
2009-03-31 $0.08B $0.01B 8.08
2008-12-31 $0.10B $0.02B 6.55
2008-09-30 $0.11B $0.02B 6.87
2008-06-30 $0.09B $0.01B 7.95
2008-03-31 $0.10B $0.01B 6.60
2007-12-31 $0.09B $0.02B 5.14
2007-09-30 $0.07B $0.01B 4.89
2007-06-30 $0.06B $0.01B 4.86
2007-03-31 $0.06B $0.01B 5.17
2006-12-31 $0.07B $0.02B 4.63
2006-09-30 $0.06B $0.01B 4.03
2006-06-30 $0.06B $0.01B 5.05
2006-03-31 $0.06B $0.01B 5.09
2005-12-31 $0.06B $0.02B 3.65
2005-09-30 $0.05B $0.01B 3.74
2005-06-30 $0.04B $0.01B 6.00
2005-03-31 $0.06B $0.03B 2.34
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $2.668B $0.522B
Quidel Corp. discovers, develops, manufactures and markets point-of-care, rapid diagnostic tests for detection of medical conditions and illnesses. These products provide accurate, rapid and cost-effective diagnostic information for acute and chronic conditions that affect women's health throughout the phases of their lives including reproductive status, pregnancy management and osteoporosis. Quidel also provides point-of-care diagnostics for infectious diseases, including influenza A and B, strep throat, H. pylori infection, chlamydia and infectious mononucleosis.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $138.463B 27.37
Medtronic (MDT) Ireland $123.238B 18.02
Stryker (SYK) United States $72.140B 26.48
Boston Scientific (BSX) United States $52.625B 25.66
Baxter (BAX) United States $39.440B 25.23
Zimmer Biomet Holdings (ZBH) United States $25.620B 16.40
Smith & Nephew SNATS (SNN) United Kingdom $17.350B 0.00
Canopy Growth (CGC) Canada $15.290B 0.00
ResMed (RMD) United States $13.957B 26.47
Aurora Cannabis (ACB) Canada $10.062B 71.00
Bio-Rad Laboratories (BIO) United States $9.398B 53.62
Hill-Rom Holdings (HRC) United States $6.885B 21.30
Perrigo (PRGO) Ireland $6.613B 10.72
Insulet (PODD) United States $5.778B 1949.40
GW Pharmaceuticals (GWPH) United Kingdom $5.086B 0.00
ICU Medical (ICUI) United States $4.899B 30.50
Haemonetics (HAE) United States $4.340B 38.50
Hutchison China MediTech (HCM) China $3.826B 0.00
Agios Pharmaceuticals (AGIO) United States $3.786B 0.00
Neogen (NEOG) United States $3.284B 50.45
NuVasive (NUVA) United States $2.842B 24.79
Aphria (APHA) $2.563B 113.78
National Vision Holdings (EYE) United States $2.360B 46.42
HEXO (HEXO) $1.416B 0.00
Cardiovascular Systems (CSII) United States $1.374B 986.50
Phibro Animal Health (PAHC) United States $1.297B 18.65
VAREX IMAGING (VREX) United States $1.256B 24.58
AtriCure (ATRC) United States $1.094B 0.00
Lantheus Holdings (LNTH) United States $0.953B 25.76
MacroGenics (MGNX) United States $0.931B 0.00
Cerus (CERS) United States $0.852B 0.00
NanoString Technologies (NSTG) United States $0.848B 0.00
Omeros (OMER) United States $0.819B 0.00
PetIQ (PETQ) United States $0.789B 22.59
OraSure Technologies (OSUR) United States $0.719B 31.51
Meridian Bioscience (VIVO) United States $0.695B 20.71
Eagle Pharmaceuticals (EGRX) United States $0.685B 23.30
TG Therapeutics (TGTX) United States $0.652B 0.00
Evolus (EOLS) United States $0.651B 0.00
Surmodics (SRDX) United States $0.641B 93.25
LeMaitre Vascular (LMAT) United States $0.620B 29.49
Quanterix (QTRX) United States $0.546B 0.00
BioLife Solutions (BLFS) United States $0.383B 157.77
Rockwell Medical (RMTI) United States $0.354B 0.00
Vapotherm (VAPO) United States $0.333B 0.00
Insys Therapeutics (INSY) United States $0.327B 0.00
Utah Medical Products (UTMD) United States $0.312B 20.27
Owens & Minor (OMI) United States $0.283B 3.91
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.266B 0.00
Bovie Medical (APYX) United States $0.262B 0.00
Cytosorbents (CTSO) United States $0.252B 0.00
Surface Oncology (SURF) United States $0.144B 0.00
Fonar (FONR) United States $0.142B 7.60
Zynex (ZYXI) United States $0.140B 15.00
Chimerix (CMRX) United States $0.103B 0.00
Chembio Diagnostics (CEMI) United States $0.101B 0.00
Female Health (VERU) United States $0.090B 0.00
United-Guardian (UG) United States $0.089B 18.54
Conatus Pharmaceuticals (CNAT) United States $0.087B 0.00
InfuSystems Holdings (INFU) United States $0.086B 0.00
CAS Medical Systems (CASM) United States $0.072B 0.00
Trinity Biotech (TRIB) Ireland $0.072B 21.43
Oramed Pharmaceuticals (ORMP) United States $0.057B 0.00
Neurotrope (NTRP) United States $0.052B 0.00
Valeritas Holdings (VLRX) United States $0.038B 0.00
ImmuCell (ICCC) United States $0.037B 0.00
Senestech (SNES) United States $0.025B 0.00
Capricor Therapeutics (CAPR) United States $0.018B 0.00
Myomo (MYO) United States $0.016B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.014B 0.00
Akers Biosciences Inc (AKER) United States $0.013B 0.00
Cellectar Biosciences (CLRB) United States $0.013B 0.00
NeuroMetrix (NURO) United States $0.008B 15.14